Reported 2 days ago
This article highlights Visa and Novartis as strong candidates for long-term dividend investment due to their solid financial performance and consistent payout history. Visa, a leading payment network, boasts a remarkable track record of increasing dividends since its public debut in 2008, supported by strong revenue and margins. Meanwhile, Novartis, a pharmaceutical giant with a history of blockbuster drugs, has maintained a 27-year streak of dividend increases and is focused on high-growth opportunities. Both companies are well-positioned to continue rewarding their shareholders.
Source: YAHOO